News
February 14, 2019
Safety of Long term use of Hydroxychloroquine Therapy Further Verified for People with Lupus
Hydroxychloroquine (Plaquenil®) was approved by the Food and Drug Administration for symptoms of lupus. The greatest concern people with lupus have when taking hydroxychloroquine is related to vision and an increase in risk for retinal damage. A new investigation analyzed the retinal changes over a five-year period in people with lupus and did not find clinically relevant retinal changes in the group. The study concludes that hydroxychloroquine therapy is safe for long-term use at doses <5 mg/kg/day. Learn about how lupus affects the eyes and hydroxychloroquine.
See More:
The latest from Inside Lupus Research
News
Phase 2 Study of Oral Brepocitinib for Systemic Lupus Erythematosus Fails
News
In Combination with Standard Therapy, Obinutuzumab Demonstrates Kidney Function Preservation and Flare Prevention in People with Lupus Nephritis
News
Latest Discoveries in Lupus Research Highlighted at ACR’s 2023 Scientific Meeting
News
Study Finds Link Between Omega 3 and Omega 6 Fatty Acid Consumption in Women with Systemic Lupus Erythematosus